Tech news
Tuesday, Oct 26, 2021

Should governments rethink their coronavirus vaccine rollouts?

China's top health official had admitted domestically produced jabs have low rates of protection.
Gao Fu said his country is considering options to boost the effectiveness of doses including mixing different brands.

That's as major side effects from other Covid-19 vaccines have slowed down vaccination drives elsewhere.

The U.S. has recommended 'pausing' the use of the Johnson & Johnson vaccine following reports of blood clots.

AstraZeneca's COVID-19 vaccine is being investigated by European regulators for similar cases..

And a new Israeli study has found the coronavirus variant discovered in South Africa can penetrate Pfizer-BioNTech’s COVID-19 vaccine to some extent.

So, do the coronavirus vaccines benefits still outweigh the risks?

Related Articles